HeartBeam announced that it entered into a strategic collaboration with AccurKardia to enhance cardiac monitoring ...

Mount Sinai researchers studying a type of heart disease known as hypertrophic cardiomyopathy (HCM) have calibrated an artificial intelligence (AI) algorithm to quickly and more specifically identify ...

I tested the Ultrahuman Ring Air for months — it’s a robust, subscription-free smart ring that competes with the likes of ...

Anumana announced that it brought its diagnostic ECG-AI technology into perioperative and acute cardiac care with Boston ...

UCSF is launching a remote patient monitoring program aimed at identifying arrhythmias in expectant mothers and improving ...

As per Future Market Insights’ latest industry analysis, the valuation for the global cardiac ambulatory monitoring market was around USD 13.9 Billion in 2022 and is projected to exhibit a CAGR close ...

Background Hypertrophic cardiomyopathy (HCM) is often underdiagnosed. Artificial intelligence (AI)-based notification of HCM ...

CONTINUOUS monitoring of heart rate recovery (HRR) using wearable ECG technology can identify individuals at higher risk of cardiovascular and metabolic disorders, achieving an 86% accuracy in risk ...

Robson continues to monitor his condition ... and undergoes regular ECG testing. Robson also carries medication he only needs to use if he feels something unusual with his heart.

In the modern era, advancements in implantable cardiac monitors are revolutionizing the landscape of cardiac healthcare. These sophisticated devices, designed to continuously track heart activity, are ...